The company has already launched its device in Japan and till now almost 3 million iQOS are sold. Philip Morris then began nationwide sales also from last April after test marketing it in major cities.
Last Friday, the U.S. Food and Drug Administration released a new set of rules for both produced and imported foods to help combat foodborne-related illnesses.
A new study released contradicted previous claim that the stop-smoking drug of Pfizer causes an increase risk of heart attacks and depression to users.
The U.S. Food and Drug Administration (FDA) already approved the use of the latest heart failure drug from Novartis. The drug, known as Entresto, was found to be potent in reducing death and hospitalizations related to cardiovascular diseases.
Johnson & Johns is under investigation by the FBI for possible prior knowledge about dangers linked to one of their medical devices, the laparoscopic power morcellator, which is supposed to provide a minimally invasive alternative to hysterectomies and removal of fibroid tumors, but in reality, may have been spreading dangerous forms of cancers among its patients.
In light of promising results conducted by an independent data monitoring committee, Pfizer’s newest treatment IBRANCE (Palbociclib) ended clinical trials early this week as phase 3 of the trials ended demonstrating improvement in progression-free survival in women who had undergone treatment for metastatic breast cancer.
FDA now proposes pharmaceutical manufacturers to undermine the FDA drug warnings and present the doctors, hospitals and customers with more latest information while selling them.
Chantix has helped many people quit smoking in the years since its release. However, on Monday the U.S. Food and Drug Administration issued a warning about the quit-smoking drug made by Pfizer Inc. According to the FDA, the drug has been associated with seizures and that some patients who drink while taking the drug may become aggressive or even black out.